505 U2 A1 Medicine Writing Assignment: Cancer Screening (Essay Sample)
Review the clinician provider guidelines and recommendations found at:
Agency for Healthcare Research and Quality [AHRQ]. (2014). Guide to clinical preventive services. Retrieved from: https://www.ahrq.gov/professionals/clinicians-providers/guidelines-recommendations/guide/index.html
and also at:
The guide to clinical preventive services. (2014, May). Recommendations of the U.S. preventive services task force. Retrieved from https://www.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/guidelines-recommendations/guide/cpsguide.pdf
For the MSN prepared nurse, knowledge of epidemiology and its application to preventive screening guidelines is important in many clinical areas; administrative, informatics, education and nurse practitioner fields. Consider you are working in a clinic and need to order a preventive screening on a patient for one of the conditions listed below. (While this is a preventative measure, it also can be a diagnostic tool in other circumstances. For this Assignment the screening is a secondary prevention measure.)
Please select one screening. Your screening methodology must come from the National Clearinghouse guidelines.
Abdominal Aortic AneurysmBreast CancerCervical CancerColon CancerDiabetes Mellitus IILung CancerExplain the guideline, the correct application of the screening, and the epidemiology behind the guidance. Content required should include epidemiologic data such as statistical information as available ex. morbidity, mortality, incidence and prevalence of condition. Identify risk factors, risk assessment, testing interval, description of the patient population, screening test recommendations and other factors relative to the guideline.
This paper should be 3 pages, and 4 references. This paper should adhere to appropriate 6th edition APA format.
For any MSN prepared nurse, being knowledgeable about epidemiology and its application into preventive screening guidelines is essential in many clinical settings such as nurse practitioner, informatics, administrative and education arenas. In this case, screening is a secondary preventive mechanism. Accordingly, this paper seeks to present a screening methodology from the National Clearing House guidelines on a patient with a breast cancer condition. Although the screening is a preventive measure, it may as well be a diagnostic tool in some situations.
The Guideline, the Correct Application of the Screening, and the Epidemiology behind the Guidance
The population eligible for breast cancer screening using the film mammography method includes women aged between forty to forty-nine years. The recommendation for screening in this age bracket is to personalize the decision before the start of biennial screening depending on the situation of a patient and the results. The second age bracket is women aged between fifty and seventy-four years whereby the recommended period of screening is after every two years. The last age bracket for this type of breast cancer screening is women aged above seventy-five years where there are no specific recommendations due to insufficient evidence (U.S Department of Health and Human Services, 2014). There is a suggestion for evaluation of risks for women aged more than forty years who are not at increased risk in cases of a known genetic mutation or a medical history of chest radiations. The correct application of screening is by means of standardization of film mammography. The epidemiology behind the guidance is the fact that the use of film mammography has resulted in improved quality of screening. There is substantial evidence that screening by film mammography decreases breast cancer mortality especially for women aged between fifty and seventy-four years (U.S Department of Health and Human Services, 2014).
The epidemiology of breast cancer has evidently changed over the previous few years. According to estimations, more than three million women in the United States had a history of breast cancer by the beginning of the year 2014. It has become the most common type of cancer diagnosed among roughly 182,000 women yearly in America (Rojas, & Stuckey, 2016). This accounts for about twenty-si
- Difference between Myasthenia Gravis and Guillain Barren SyndromeDescription: Is the nursing diagnoses that you selected appropriate for the patient with a diagnosis of myasthenia gravis, Guillain-Barre syndrome or both?...1 page/≈275 words| 3 Sources | APA | Health, Medicine, Nursing | Essay |
- Measles Immunization and EradicationDescription: What measles immunization priorities should be considered in conflict and humanitarian emergency situations and how does this differ from normal situations?...1 page/≈275 words| 2 Sources | APA | Health, Medicine, Nursing | Essay |
- Outcome MeasuresDescription: Outcome Measures. Challenges that may be faced because of this shift Health and Medicine Essay Undergraduate level...3 pages/≈825 words| 2 Sources | APA | Health, Medicine, Nursing | Essay |